Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis research principles and priorities in children and adolescents: an international consensus statement.

The Lancet. Child & adolescent health·2026
Same author

Decentralisation and integration of paediatric tuberculosis services to primary healthcare facilities as an approach to optimise management in Cameroon and Kenya: a descriptive cohort study.

BMJ public health·2025
Same author

Childhood tuberculosis: robust funding and integrated solutions needed now.

The Lancet. Child & adolescent health·2025
Same author

Assessing tuberculosis clinical presentation, diagnosis and treatment outcomes among children under 5 years old: results from a cohort of children with presumptive TB in Cameroon and Kenya.

BMJ public health·2025
Same author

COVID-19, tuberculosis, and HIV triad: a prospective observational study in ambulatory patients in Kenya, Uganda, and South Africa.

PLOS global public health·2025
Same author

Leveraging nutritional rehabilitation and tuberculosis programmes to tackle tuberculosis and severe acute malnutrition in children.

The Lancet. Child & adolescent health·2025

Related Experiment Video

Updated: Jun 7, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

New diagnostics for tuberculosis: fulfilling patient needs first.

Jean-François Lemaire1, Martina Casenghi

  • 1Médecins Sans Frontières Campaign for Access to Essential Medicines, Geneva, Switzerland.

Journal of the International AIDS Society
|October 27, 2010
PubMed
Summary

Developing new tuberculosis (TB) diagnostic tests requires understanding patient needs in resource-limited settings. Minimal specifications are crucial for effective point-of-care TB diagnostics, especially for vulnerable populations.

Related Experiment Videos

Last Updated: Jun 7, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Area of Science:

  • Medical Diagnostics
  • Public Health
  • Infectious Disease Research

Background:

  • Effective tuberculosis (TB) control hinges on early diagnosis and treatment.
  • Current TB diagnostics are often high-infrastructure dependent, unsuitable for resource-limited settings.
  • Existing tests exhibit poor performance in diagnosing TB in children, HIV/AIDS patients, and extrapulmonary cases.

Purpose of the Study:

  • To identify minimal test specifications for a new TB point-of-care diagnostic test.
  • To align diagnostic development with urgent medical and patient needs in resource-limited settings.
  • To address challenges in developing low-cost, patient-needs-driven TB diagnostics for vulnerable groups.

Main Methods:

  • Conducted survey interviews with field practitioners to identify priority medical needs.
  • Convened an expert meeting with diverse stakeholders to define minimal test specifications.
  • Analyzed gaps and potential solutions for developing new TB diagnostic tests.

Main Results:

  • Identified critical medical needs for new TB diagnostics in resource-limited areas.
  • Defined minimal specifications for a patient-needs-driven TB point-of-care test.
  • Highlighted key gaps including biomarker discovery, platform simplification, and reference standards.

Conclusions:

  • New TB point-of-care tests must meet minimal specifications driven by urgent medical needs.
  • Addressing gaps in biomarkers, technology, specimen banking, and reference standards is essential.
  • Innovative R&D funding mechanisms, like prize funds, can accelerate the development of needed TB diagnostics.